Table 5: The prevalence of intestinal protozoa and helminths among immunocompromised patients.
Reference |
No. examined |
Immunocompromised patients |
% Infected |
|
Protozoa |
Helminth |
|||
Mahdi, et al. [48] |
101 |
62 Males and 39 females with malignant diseases attending Oncology Centre of Basrah Teaching Hospital. Age 9 months-16 years old. |
28.7 |
10.9 |
Mahdi & Al-Saadoon [49] |
58 |
Males (37) and females (21) attending the Oncology centre of Basrah Maternity & Child Hospital. Microsporidium was at a rate 10.34% among Hodgkin and non-hodgkin lymphoma (83.3%) |
32.75 |
0 |